Immunologic Considerations for Therapeutic Strategies Utilizing Allogeneic Hepatocytes: Hepatocyte–Expressed Membrane–Bound Major Histocompatibility Complex Class I Antigen Sensitizes While Soluble Antigen Suppresses the Immune Response in Rats
Open Access
- 1 November 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 32 (5) , 999-1007
- https://doi.org/10.1053/jhep.2000.19255
Abstract
Understanding the immunologic effects of hepatocytes is critical because of the potential to use these cells for bioartificial livers, as a vehicle for gene transfer, and as a means to induce donor–specific immunosuppression in organ transplantation. However, this understanding is complicated by the fact that hepatocytes express membrane–bound and soluble forms of major histocompatibility complex (MHC) class I antigen, each with the potential to induce different immune responses. In the present study we first determined the immunologic effect of normal donor–derived hepatocytes in a rat heart transplant model. We then used ex vivo hepatocyte gene transfer to examine the immunologic effects of different forms of hepatocyte–expressed MHC class I antigen. Results showed that intrasplenic injection of purified, donor–strain-specific hepatocytes into recipients primes alloimmunity, as evidenced by acceleration of heart allograft rejection. Interestingly, injection of autologous hepatocytes transfected ex vivo with DNA encoding only membrane–bound donor MHC class I antigen (RT1.Aa) also accelerated allograft rejection. However, hepatocytes transfected to express only secreted donor MHC antigen prolonged transplant survival. Limiting–dilution analysis of lymphocytes from animals treated with hepatocytes producing only secreted alloantigen showed an antigen–specific reduction in cytotoxic T lymphocyte (CTL) and helper T lymphocyte (HTL) precursors. Further analysis of CTL populations by flow cytometry revealed a relatively high percentage of nonviable cells, implying that soluble antigen promotes allospecific CTL death. In summary, this study suggests that hepatocyte–expressed MHC class I molecules have opposing immunologic effects, with the membrane–bound antigen inducing immunologic sensitization, and the soluble antigen promoting donor–specific immunosuppression.Keywords
This publication has 46 references indexed in Scilit:
- Are dendritic cells the key to liver transplant tolerance?Immunology Today, 1999
- Nonspecific Inflammation Inhibits Adenovirus-Mediated Pulmonary Gene Transfer and Expression Independent of Specific Acquired Immune ResponsesHuman Gene Therapy, 1998
- Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I moleculesHuman Immunology, 1998
- Soluble form of an HLA-B7 class I antigen specifically suppresses humoral alloimmunizationHuman Immunology, 1994
- Organ graft tolerance: the liver effectThe Lancet, 1994
- Effect of HLA phenotype and gender on expression of various forms of class I HLA in plasmaHuman Immunology, 1991
- Examination of serum class I antigen in liver-transplanted ratsClinical and Experimental Immunology, 1991
- ABROGATION OF THE INDUCTION OF PORTAL VENOUS TOLERANCE IN A CARDIAC TRANSPLANT MODEL RESULTING FROM KUPFFER CELL INHIBITION BY GADOLINIUMTransplantation, 1990
- COMPARISON OF IN VIVO AND IN VITRO IMMUNE RESPONSE TO PURIFIED HEPATOCYTESTransplantation, 1990
- Transplantation tolerance and immunosuppression following liver grafting in ratsImmunology Today, 1985